Epilepsia · 2005 · 34 citations · 7 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAntiepileptic PharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyBipolar Disorder PharmacotherapyMood Stabilizer PharmacotherapyAntiepileptic Drug EfficacyAntiepileptic Drug PharmacokineticsAntipsychotic Medication UseAtypical Antipsychotic TreatmentBipolar MedicationOlanzapine PharmacologyRisperidone TherapySteady-state Plasma Concentration
PURPOSE: Oxcarbazepine (OZC) is a second-generation antiepileptic drug (AED) that also may be used as a mood stabilizer. Unlike carbamazepine (CBZ), which is an inducer of the cytochrome P-450 isoforms and may accelerate the elimination of several therapeutic agents, OXC seems to have only a modest inducing action. The aim of this investigation was to evaluate the effect of a treatment with OXC on plasma concentrations of the new antipsychotics risperidone and olanzapine. METHODS: OXC, at a dosage of 900-1,200 mg/day, was administered for 5 consecutive weeks to 25 outpatients, 10 men and 15 women, aged 25 to 64 years, with bipolar or schizoaffective disorder. Twelve patients were stabilized on risperidone therapy (2-6 mg/day) and 13 on olanzapine (5-20 mg/day). Steady-state plasma concentrations of risperidone and its active metabolite 9-hydroxyrisperidone (9-OH-risperidone) and olanzapine were measured by high-pressure liquid chromatography (HPLC) before addition of OXC and after 5 weeks from the start of adjunctive treatment. RESULTS: OXC caused only minimal and no significant changes in the mean plasma levels of risperidone (from 5.6 +/- 3.6 ng/ml at baseline to 4.8 +/- 2.6 ng/ml at week 5), 9-OH-risperidone (from 23.6 +/- 7.5 to 24.7 +/- 7.4 ng/ml), and olanzapine (from 26.5 +/- 5.7 ng/ml at baseline to 27.8 +/- 5.1 ng/ml). OXC coadministration with either risperidone or olanzapine was well tolerated. CONCLUSIONS: Our findings indicate that OXC does not affect the elimination of risperidone and olanzapine, thus confirming its weak inducing effect on hepatic drug-metabolizing enzymes.
7
Induction of Ethinylestradiol and Levonorgestrel Metabolism by Oxcarbazepine in Healthy Women
Cinzia Fattore, Giovanna Cipolla, G. Gatti et al. · Epilepsia · 1999 · 164 citations · Full text
Angela Avenoso, Gabriella Facciolà, Monica Salemi et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2000 · 94 citations